Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

March 1, 2010

Primary Completion Date

October 1, 2010

Study Completion Date

October 1, 2010

Conditions
Myelodysplastic Syndrome
Trial Locations (15)

10065

Memorial Sloan-Kettering Cancer Center, New York

21231

John Hopkins University Hospital, Baltimore

27157

Wake Forest University, Winston-Salem

30060

Northwest Georgia Oncology Centers, P.C., Marietta

33612

H. Lee Moffitt Cancer Center, Tampa

34461

Cancer & Blood Disease Center, Lecanto

44195

The Cleveland Clinic Foundation, Cleveland

55905

Mayo Clinic - Rochester, Rochester

60611

Hematology Oncology Associates of Illinois, Chicago

60612

Rush University Medical Center, Chicago

60637

University of Chicago, Chicago

85259

Mayo Clinic - Scottsdale, Scottsdale

94305

Stanford University Cancer Center, Stanford

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

D-47166

St. Johannes Hospital, Duisburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY